DexCom Revenue 2010-2024 | DXCM
DexCom annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- DexCom revenue for the quarter ending December 31, 2024 was $1.114B, a 7.64% increase year-over-year.
- DexCom revenue for the twelve months ending December 31, 2024 was $4.033B, a 11.34% increase year-over-year.
- DexCom annual revenue for 2024 was $4.033B, a 11.34% increase from 2023.
- DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022.
- DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021.
| DexCom Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $4,033 |
| 2023 | $3,622 |
| 2022 | $2,910 |
| 2021 | $2,449 |
| 2020 | $1,927 |
| 2019 | $1,476 |
| 2018 | $1,032 |
| 2017 | $719 |
| 2016 | $573 |
| 2015 | $402 |
| 2014 | $259 |
| 2013 | $160 |
| 2012 | $100 |
| 2011 | $76 |
| 2010 | $49 |
| 2009 | $30 |
| DexCom Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,114 |
| 2024-09-30 | $994 |
| 2024-06-30 | $1,004 |
| 2024-03-31 | $921 |
| 2023-12-31 | $1,035 |
| 2023-09-30 | $975 |
| 2023-06-30 | $871 |
| 2023-03-31 | $742 |
| 2022-12-31 | $815 |
| 2022-09-30 | $770 |
| 2022-06-30 | $696 |
| 2022-03-31 | $629 |
| 2021-12-31 | $698 |
| 2021-09-30 | $650 |
| 2021-06-30 | $595 |
| 2021-03-31 | $505 |
| 2020-12-31 | $569 |
| 2020-09-30 | $501 |
| 2020-06-30 | $452 |
| 2020-03-31 | $405 |
| 2019-12-31 | $463 |
| 2019-09-30 | $396 |
| 2019-06-30 | $336 |
| 2019-03-31 | $281 |
| 2018-12-31 | $338 |
| 2018-09-30 | $267 |
| 2018-06-30 | $243 |
| 2018-03-31 | $184 |
| 2017-12-31 | $221 |
| 2017-09-30 | $185 |
| 2017-06-30 | $171 |
| 2017-03-31 | $142 |
| 2016-12-31 | $171 |
| 2016-09-30 | $149 |
| 2016-06-30 | $137 |
| 2016-03-31 | $116 |
| 2015-12-31 | $131 |
| 2015-09-30 | $105 |
| 2015-06-30 | $93 |
| 2015-03-31 | $73 |
| 2014-12-31 | $84 |
| 2014-09-30 | $69 |
| 2014-06-30 | $59 |
| 2014-03-31 | $47 |
| 2013-12-31 | $52 |
| 2013-09-30 | $43 |
| 2013-06-30 | $36 |
| 2013-03-31 | $30 |
| 2012-12-31 | $33 |
| 2012-09-30 | $23 |
| 2012-06-30 | $23 |
| 2012-03-31 | $20 |
| 2011-12-31 | $22 |
| 2011-09-30 | $18 |
| 2011-06-30 | $21 |
| 2011-03-31 | $14 |
| 2010-12-31 | $16 |
| 2010-09-30 | $12 |
| 2010-06-30 | $12 |
| 2010-03-31 | $10 |
| 2009-12-31 | $10 |
| 2009-09-30 | $7 |
| 2009-06-30 | $7 |
| 2009-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $34.912B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.048B | 99.11 |
| Thermo Fisher Scientific (TMO) | United States | $205.720B | 24.60 |
| Alcon (ALC) | Switzerland | $44.180B | 29.56 |
| Edwards Lifesciences (EW) | United States | $44.064B | 28.51 |
| IDEXX Laboratories (IDXX) | United States | $37.082B | 42.44 |
| IQVIA Holdings (IQV) | United States | $34.165B | 18.93 |
| Mettler-Toledo (MTD) | United States | $27.257B | 31.66 |
| Waters (WAT) | United States | $22.611B | 32.08 |
| STERIS (STE) | Ireland | $21.693B | 24.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.328B | 0.00 |
| Hologic (HOLX) | United States | $14.433B | 15.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.462B | 13.82 |
| Penumbra (PEN) | United States | $11.675B | 105.62 |
| Sysmex ADR (SSMXY) | Japan | $11.519B | 36.12 |
| Globus Medical (GMED) | United States | $11.454B | 26.79 |
| Masimo (MASI) | United States | $9.488B | 45.91 |
| Glaukos (GKOS) | United States | $8.676B | 0.00 |
| Teleflex (TFX) | United States | $8.134B | 12.97 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.536B | 25.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.412B | 0.00 |
| Veracyte (VCYT) | United States | $3.181B | 95.46 |
| Nihon Kohden (NHNKY) | Japan | $2.671B | 14.60 |
| LivaNova (LIVN) | United Kingdom | $2.606B | 15.04 |
| TransMedics (TMDX) | United States | $2.532B | 80.27 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 21.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.110B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.700B | 8.88 |
| Alphatec Holdings (ATEC) | United States | $1.512B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.230B | 0.00 |
| RxSight (RXST) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.208B | 80.06 |
| OPKO Health (OPK) | United States | $1.140B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.894B | 0.00 |
| AxoGen (AXGN) | United States | $0.814B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.793B | 17.33 |
| SiBone (SIBN) | United States | $0.755B | 0.00 |
| IRadimed (IRMD) | United States | $0.724B | 38.09 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.711B | 12.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.497B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| ClearPoint Neuro (CLPT) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.425B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.363B | 19.47 |
| Anteris Technologies Global (AVR) | Australia | $0.297B | 0.00 |
| Inogen (INGN) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.222B | 0.00 |
| Nevro (NVRO) | United States | $0.215B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.140B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 13.90 |
| Lucid Diagnostics (LUCD) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| Hyperfine (HYPR) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 32.14 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |